Overview
Background
Dr Natacha Omer is a paediatic oncologist at the Queensland Children's Hospital in Brisbane. She is specialised in solid tumours, with a spacial interest in paediatric and adolescent sarcomas, cancer immunotherapy and molecular oncology. She is undertaking a PhD in immunology studying natural killer (NK) cell immunotherapy in paediatric sarcomas at the Frazer Institute, University of Queensland, in Dr Fernando Guimaraes lab.
Availability
- Dr Natacha Omer is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Medicine, Université Rene Descartes Paris 5
- Masters (Research) of Tumour Immunology, Université Rene Descartes Paris 5
Works
Search Professor Natacha Omer’s works on UQ eSpace
2024
Journal Article
Precision-guided treatment in high-risk pediatric cancers
Lau, Loretta M. S., Khuong-Quang, Dong-Anh, Mayoh, Chelsea, Wong, Marie, Barahona, Paulette, Ajuyah, Pamela, Senapati, Akanksha, Nagabushan, Sumanth, Sherstyuk, Alexandra, Altekoester, Ann-Kristin, Fuentes-Bolanos, Noemi A., Yeung, Veronica, Sullivan, Ashleigh, Omer, Natacha, Diamond, Yonatan, Jessop, Sophie, Battaglia, Lauren, Zhukova, Nataliya, Cui, Louise, Lin, Angela, Gifford, Andrew J., Fleuren, Emmy D. G., Dalla-Pozza, Luciano, Moore, Andrew S., Khaw, Seong-Lin, Eisenstat, David D., Gottardo, Nicholas G., Wood, Paul J., Tapp, Heather ... Ziegler, David S. (2024). Precision-guided treatment in high-risk pediatric cancers. Nature Medicine, 30 (7), 1913-1922. doi: 10.1038/s41591-024-03044-0
2024
Journal Article
TGF-β signalling limits effector function capacity of NK cell anti-tumour immunity in human bladder cancer
Wong, Joshua K. M., McCulloch, Timothy R., Alim, Louisa, Omer, Natacha, Mehdi, Ahmed M., Tuong, Zewen Kelvin, Bonfim-Melo, Alexis, Chung, Eric, Nicol, Alice, Simpson, Fiona, Rhee, Handoo, Rossi, Gustavo Rodrigues and Souza-Fonseca-Guimaraes, Fernando (2024). TGF-β signalling limits effector function capacity of NK cell anti-tumour immunity in human bladder cancer. EBioMedicine, 104 105176. doi: 10.1016/j.ebiom.2024.105176
2024
Journal Article
High-dose chemotherapy for Ewing sarcoma and Rhabdomyosarcoma: A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party
Ramamurthy, Ashika, Connolly, Elizabeth A, Mar, Jasmine, Lewin, Jeremy, Bhadri, Vivek A, Phillips, Marianne B, Winstanley, Mark, Orme, Lisa M, Grimison, Peter, Connor, Joanna, Lazarakis, Smaro, Hong, Angela M, Omer, Natacha and Cayrol, Julie (2024). High-dose chemotherapy for Ewing sarcoma and Rhabdomyosarcoma: A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party. Cancer Treatment Reviews, 124 102694. doi: 10.1016/j.ctrv.2024.102694
2023
Journal Article
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
Mayoh, Chelsea, Gifford, Andrew J., Terry, Rachael, Lau, Loretta M S, Wong, Marie, Rao, Padmashree, Shai-Hee, Tyler, Saletta, Federica, Khuong-Quang, Dong-Anh, Qin, Vicky, Mateos, Marion K., Meyran, Deborah, Miller, Katherine E., Yuksel, Aysen, Mould, Emily V A, Bowen-James, Rachel, Govender, Dinisha, Senapati, Akanksha, Zhukova, Nataliya, Omer, Natacha, Dholaria, Hetal, Alvaro, Frank, Tapp, Heather, Diamond, Yonatan, Pozza, Luciano Dalla, Moore, Andrew S., Nicholls, Wayne, Gottardo, Nicholas G., McCowage, Geoffrey ... Ekert, Paul G. (2023). A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer. Genome Medicine, 15 (1) 20, 20. doi: 10.1186/s13073-023-01170-x
2021
Journal Article
Enhancing the potential of immunotherapy in paediatric sarcomas: breaking the immunosuppressive barrier with receptor tyrosine kinase inhibitors
Fleuren, Emmy D. G., Terry, Rachael L., Meyran, Deborah, Omer, Natacha, Trapani, Joseph A., Haber, Michelle, Neeson, Paul J. and Ekert, Paul G. (2021). Enhancing the potential of immunotherapy in paediatric sarcomas: breaking the immunosuppressive barrier with receptor tyrosine kinase inhibitors. Biomedicines, 9 (12) 1798, 1798. doi: 10.3390/biomedicines9121798
2021
Journal Article
Enhancing natural killer cell targeting of pediatric sarcoma
Omer, Natacha, Nicholls, Wayne, Ruegg, Bronte, Souza-Fonseca-Guimaraes, Fernando and Rossi, Gustavo Rodrigues (2021). Enhancing natural killer cell targeting of pediatric sarcoma. Frontiers in Immunology, 12 791206, 791206. doi: 10.3389/fimmu.2021.791206
2021
Journal Article
Chimeric antigen receptor T cell therapy and the immunosuppressive tumor microenvironment in pediatric sarcoma
Terry, Rachael L., Meyran, Deborah, Fleuren, Emmy D. G., Mayoh, Chelsea, Zhu, Joe, Omer, Natacha, Ziegler, David S., Haber, Michelle, Darcy, Phillip K., Trapani, Joseph A., Neeson, Paul J. and Ekert, Paul G. (2021). Chimeric antigen receptor T cell therapy and the immunosuppressive tumor microenvironment in pediatric sarcoma. Cancers, 13 (18) 4704, 4704. doi: 10.3390/cancers13184704
2021
Conference Publication
Precision medicine search for paediatric oncology
Koopman, Bevan, Wright, Tracey, Omer, Natacha, McCabe, Veronica and Zuccon, Guido (2021). Precision medicine search for paediatric oncology. 44th International ACM SIGIR Conference on Research and Development in Information Retrieval, Virtual, 11 - 15 July, 2021. New York, NY, United States: Association for Computing Machinery. doi: 10.1145/3404835.3462792
2020
Conference Publication
Precision medicine for paediatric high-grade diffuse midline gliomas - results from the zero childhood cancer comprehensive precision medicine program
Khuong-Quang, Dong-Anh, Nagabushan, Sumanth, Manoharan, Neevika, Arndt, Greg, Barahona, Paulette, Cowley, Mark J, Ekert, Paul G, Failes, Tim, Bolanos, Noemi Fuentes, Gauthier, Maely, Gifford, Andrew J, Haber, Michelle, Kumar, Amit, Lock, Richard B, Marshall, Glenn M, Mayoh, Chelsea, Mould, Emily, Norris, Murray D, Gopalakrishnan, Anjana, Omer, Natacha, Trebilcock, Peter, Trahair, Toby N, Tsoli, Maria, Tucker, Katherine, Wong, Marie, Tyrrell, Vanessa, Lau, Loretta and S, Ziegler, David (2020). Precision medicine for paediatric high-grade diffuse midline gliomas - results from the zero childhood cancer comprehensive precision medicine program. 19th International Symposium on Pediatric Neuro-Oncology (ISPNO 2020), Karuizawa, Japan, 13-16 December 2020. Cary, NC, United States: Oxford University Press . doi: 10.1093/neuonc/noaa222.117
2017
Journal Article
Phase-II trials in osteosarcoma recurrences: a systematic review of past experience
Omer, Natacha, Le Deley, Marie-Cecile, Piperno-Neumann, Sophie, Marec-Berard, Perrine, Italiano, Antoine, Corradini, Nadege, Bellera, Carine, Brugieres, Laurence and Gaspar, Nathalie (2017). Phase-II trials in osteosarcoma recurrences: a systematic review of past experience. European Journal of Cancer, 75, 98-108. doi: 10.1016/j.ejca.2017.01.005
Funding
Current funding
Supervision
Availability
- Dr Natacha Omer is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Media
Enquiries
For media enquiries about Dr Natacha Omer's areas of expertise, story ideas and help finding experts, contact our Media team: